527 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
51 | 32275773 | P-Glycoprotein Inhibition Exacerbates Paclitaxel Neurotoxicity in Neurons and Patients With Cancer. | 2020 Sep | 5 |
52 | 32353410 | FNDC5 promotes paclitaxel sensitivity of non-small cell lung cancers via inhibiting MDR1. | 2020 Aug | 2 |
53 | 32401925 | Treatment with β-elemene combined with paclitaxel inhibits growth, migration, and invasion and induces apoptosis of ovarian cancer cells by activation of STAT-NF-κB pathway. | 2020 | 1 |
54 | 32457290 | Decreased expression of FBXW7 by ERK1/2 activation in drug-resistant cancer cells confers transcriptional activation of MDR1 by suppression of ubiquitin degradation of HSF1. | 2020 May 26 | 1 |
55 | 32489129 | Hyaluronic acid reduction-sensitive polymeric micelles achieving co-delivery of tumor-targeting paclitaxel/apatinib effectively reverse cancer multidrug resistance. | 2020 Dec | 1 |
56 | 32497533 | The SMAC mimetic LCL161 is a direct ABCB1/MDR1-ATPase activity modulator and BIRC5/Survivin expression down-regulator in cancer cells. | 2020 Aug 15 | 2 |
57 | 32536602 | Chemotherapy-Induced IL8 Upregulates MDR1/ABCB1 in Tumor Blood Vessels and Results in Unfavorable Outcome. | 2020 Jul 15 | 2 |
58 | 32564116 | ABCB1 and ERCC1 gene polymorphisms are associated with nephro- and hepatotoxicity to carboplatin/paclitaxel-based chemotherapy in patients with gynecologic cancers. | 2020 Oct | 3 |
59 | 32569926 | Synthesis and biological evaluation of thiophenylbenzofuran derivatives as potential P-glycoprotein inhibitors. | 2020 Sep 1 | 2 |
60 | 32643224 | Carrier-Free Delivery of Precise Drug-Chemogene Conjugates for Synergistic Treatment of Drug-Resistant Cancer. | 2020 Oct 5 | 2 |
61 | 32707710 | The Multidrug Resistance-Reversing Activity of a Novel Antimicrobial Peptide. | 2020 Jul 19 | 4 |
62 | 32872293 | Metformin Derivative HL156A Reverses Multidrug Resistance by Inhibiting HOXC6/ERK1/2 Signaling in Multidrug-Resistant Human Cancer Cells. | 2020 Aug 28 | 1 |
63 | 32887626 | Dual drug-loaded nano-platform for targeted cancer therapy: toward clinical therapeutic efficacy of multifunctionality. | 2020 Sep 4 | 2 |
64 | 32903706 | Antimicrobial Peptide Reverses ABCB1-Mediated Chemotherapeutic Drug Resistance. | 2020 | 1 |
65 | 32984343 | Bruton's Tyrosine Kinase (BTK) Inhibitor RN486 Overcomes ABCB1-Mediated Multidrug Resistance in Cancer Cells. | 2020 | 2 |
66 | 33050126 | Homotype-Targeted Biogenic Nanoparticles to Kill Multidrug-Resistant Cancer Cells. | 2020 Oct 9 | 2 |
67 | 33163405 | Sapitinib Reverses Anticancer Drug Resistance in Colon Cancer Cells Overexpressing the ABCB1 Transporter. | 2020 | 1 |
68 | 33207738 | Combination of Inhibitors of USP7 and PLK1 has a Strong Synergism against Paclitaxel Resistance. | 2020 Nov 16 | 2 |
69 | 33280384 | Structure-Based Design, Synthesis, and Biological Evaluation of New Triazolo[1,5-a]Pyrimidine Derivatives as Highly Potent and Orally Active ABCB1 Modulators. | 2020 Dec 24 | 2 |
70 | 29956630 | Formulation, Pharmacokinetic Evaluation and Cytotoxicity of an Enhanced- penetration Paclitaxel Nanosuspension. | 2019 | 2 |
71 | 30230544 | Chloride channel-3 mediates multidrug resistance of cancer by upregulating P-glycoprotein expression. | 2019 May | 1 |
72 | 30317630 | Androgen receptor transcriptional activity and chromatin modifications on the ABCB1/MDR gene are critical for taxol resistance in ovarian cancer cells. | 2019 Jun | 6 |
73 | 30367323 | Chemotherapy in pregnancy: exploratory study of the effects of paclitaxel on the expression of placental drug transporters. | 2019 Oct | 4 |
74 | 30391357 | Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo. | 2019 Feb 1 | 2 |
75 | 30711936 | AS602801 Sensitizes Ovarian Cancer Stem Cells to Paclitaxel by Down-regulating MDR1. | 2019 Feb | 3 |
76 | 30765569 | Structural insight into substrate and inhibitor discrimination by human P-glycoprotein. | 2019 Feb 15 | 2 |
77 | 30790579 | Inhibitory effects of flavonoids on P-glycoprotein in vitro and in vivo: Food/herb-drug interactions and structure-activity relationships. | 2019 Apr 15 | 2 |
78 | 30894541 | Multiple ABCB1 transcriptional fusions in drug resistant high-grade serous ovarian and breast cancer. | 2019 Mar 20 | 1 |
79 | 30911326 | Combination of shikonin with paclitaxel overcomes multidrug resistance in human ovarian carcinoma cells in a P-gp-independent manner through enhanced ROS generation. | 2019 | 2 |
80 | 31103263 | Intracellular Doppler Spectroscopy detects altered drug response in SKOV3 tumor spheroids with silenced or inhibited P-glycoprotein. | 2019 Jul 5 | 3 |
81 | 31106148 | Glesatinib, a c-MET/SMO Dual Inhibitor, Antagonizes P-glycoprotein Mediated Multidrug Resistance in Cancer Cells. | 2019 | 1 |
82 | 31123858 | Impact of gene polymorphisms on the systemic toxicity to paclitaxel/carboplatin chemotherapy for treatment of gynecologic cancers. | 2019 Aug | 1 |
83 | 31127007 | Evidence for the Interaction of A3 Adenosine Receptor Agonists at the Drug-Binding Site(s) of Human P-glycoprotein (ABCB1). | 2019 Aug | 2 |
84 | 31156720 | Cotargeting Plk1 and androgen receptor enhances the therapeutic sensitivity of paclitaxel-resistant prostate cancer. | 2019 | 1 |
85 | 31190887 | Mitochondria P-glycoprotein confers paclitaxel resistance on ovarian cancer cells. | 2019 | 2 |
86 | 31196356 | Nano-Porous Silica Aerogels as Promising Biomaterials for Oral Drug Delivery of Paclitaxel. | 2019 Jul 1 | 4 |
87 | 31248184 | A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor. | 2019 Jun 19 | 1 |
88 | 31336860 | Gliotoxin Enhances Autophagic Cell Death via the DAPK1-TAp63 Signaling Pathway in Paclitaxel-Resistant Ovarian Cancer Cells. | 2019 Jul 12 | 1 |
89 | 31350703 | Involvement of the MDR1 gene and glycolipids in anticancer drug-resistance of human ovarian carcinoma-derived cells. | 2019 Oct | 4 |
90 | 31404980 | Deciphering Hydrodynamic and Drug-Resistant Behaviors of Metastatic EMT Breast Cancer Cells Moving in a Constricted Microcapillary. | 2019 Aug 9 | 1 |
91 | 31467112 | Breast Cancer Risk-Associated SNPs in the mTOR Promoter Form De Novo KLF5- and ZEB1-Binding Sites that Influence the Cellular Response to Paclitaxel. | 2019 Nov | 3 |
92 | 31476282 | Derivative of 5-cyano-6-phenylpyrimidin antagonizes ABCB1- and ABCG2-mediated multidrug resistance. | 2019 Nov 15 | 1 |
93 | 31536779 | In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆. | 2019 Dec 1 | 1 |
94 | 31570440 | Apatinib Reverses Paclitaxel-resistant Lung Cancer Cells (A549) Through Blocking the Function of ABCB1 Transporter. | 2019 Oct | 4 |
95 | 31571407 | ABCB1 polymorphism predicts the toxicity and clinical outcome of lung cancer patients with taxane-based chemotherapy. | 2019 Nov | 1 |
96 | 31801248 | Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 Expression. | 2019 Nov 30 | 1 |
97 | 31867270 | Targeting of the Eukaryotic Translation Initiation Factor 4A Against Breast Cancer Stemness. | 2019 | 1 |
98 | 28771725 | TLR4 and NFκB signaling is critical for taxol resistance in ovarian carcinoma cells. | 2018 Mar | 6 |
99 | 29208281 | Overcoming STC2 mediated drug resistance through drug and gene co-delivery by PHB-PDMAEMA cationic polyester in liver cancer cells. | 2018 Feb 1 | 2 |
100 | 29251928 | Comprehensive Synthesis of Amino Acid-Derived Thiazole Peptidomimetic Analogues to Understand the Enigmatic Drug/Substrate-Binding Site of P-Glycoprotein. | 2018 Feb 8 | 2 |